Current role of cannabis in therapeutics: A critical perspective. (PubMed, Farm Hosp) - Sep 5, 2026 - "For spasticity in multiple sclerosis, preparations such as nabiximols reduce patients' perception of symptoms, although there is a high discontinuation rate due to lack of efficacy or adverse effects...In conclusion, although cannabis may offer certain benefits, its integration into modern clinical practice should be cautious, individualized, and carried out under strict clinical supervision. The analysis of real-world use data will undoubtedly provide valuable insights."
Journal • Anorexia • Chemotherapy-Induced Nausea and Vomiting • CNS Disorders • Epilepsy • Fibromyalgia • Glaucoma • Mood Disorders • Movement Disorders • Multiple Sclerosis • Musculoskeletal Pain • Neuralgia • Ophthalmology • Pain • Pediatrics • Psychiatry • Rheumatology
|
|
Eduardo López Briz; Inmaculada Pitarch Castellano; Jesus de Santiago Moraga; Margarita Majem Tarruella; Patricia Smeyers Dura
|